By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Boston Therapeutics, Inc. 

1750 Elm Street
Suite 103
Manchester  New Hampshire  03104  U.S.A.
Phone: 603-935-9799 Fax: 603-685-4784



Company News
Boston Therapeutics Announces Innovation Grant 10/14/2016 7:11:23 AM
Boston Therapeutics Reports Positive Topline Data From Proof Of Concept Asia Trial 10/7/2016 10:56:58 AM
Boston Therapeutics Completes Private Offering, Appoints New CEO 10/4/2016 12:48:15 PM
Boston Therapeutics' sugardown(R) In Clinical Trials Reduces Glucose, Fructose And Insulin 12/29/2015 9:00:47 AM
Boston Therapeutics Reports Third Quarter Results And Provides Corporate Update 11/23/2015 12:40:31 PM
Boston Therapeutics, Inc. Completes Enrollment For BTI-320 Clinical Trial 10/7/2015 1:20:38 PM
Boston Therapeutics, Inc. Pays Off Convertible Promissory Notes 10/1/2015 1:03:10 PM
Boston Therapeutics, Inc. Reports Second Quarter Results And Provides Corporate Update 8/14/2015 10:37:22 AM
Boston Therapeutics, Inc. Nominates Philip Getter To Board Of Directors 8/6/2015 10:03:56 AM
Boston Therapeutics, Inc. ' Hong Kong Affiliate Advance Pharmaceutical's BTI-320 Clinical Trial Reaches Mid-Point By Enrolling 30 Patients At The Chinese University Of Hong Kong 7/8/2015 10:46:59 AM